Related Image: Space Radiation a Risk for Astronauts |
(Date:7/24/2008)...clinical trial results could lead to availability ...reatment for deep lines and wrinkles by 2009. , ...y 24, 2008 -- Gel-Del Technologies , a St. Paul, ...d that it has concluded clinical trials of Cosmeta...ials say holds potential to be a more effective al...
(Date:7/23/2008)... the Financing Needs of European and A... YORK, July 24 /PRNewswire/ -- Paul Capital Partne...en promoted to Partner. Based in Paul,Capital,s Lo...ng,evaluating and negotiating European and Asian ...apital Healthcare funds., "Since he joined Paul C...
(Date:7/23/2008)...out-of-state intended parents, SAN RAMON, Calif.,...reme Court decision to allow gay couples to marry ...ence Center of the Bay Area (RSC), one of,the stat...nd lesbians for,infertility treatment., "Californ...C,s,long-held views that procreation is a natural ...
(Date:7/23/2008)...Call/ -- The Hanover Insurance Group,a leading su...announced it,is prepared to respond to claims resu...ugh southern Texas today., (Logo: http://www.new... are deeply concerned about individuals and busine...ent of The Hanover,s Central Region. "Our,staff is...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2...e of the opinion that eating nuts about twice a we...antly.// The study that was presented at the Worl...two servings of eight grams of nuts that would be ...ight reduce the risk of heart disease by as much a...
... the third leading cause of death in Canada ahead ...o a prevalent problem within Aboriginal communitie... on September 10, 2006, two experts from the Canad...lable to comment on the health challenges posed by...
...to the federal Liberal leadership hopeful Bob Rae,...m, which would prevent patients from having to cho.... As part of his effort to succeed Paul Martin as...ae unveiled a six-point health-care campaign platf...
...d traditional healers in Ghana claim to have devel...boosts the immune system in much the same way as A...system in HIV patients. Ghana Aids Commission (GAC...Opportunities Industrialization Centre (OIC) are a...
Other Medicine News:Health News:Getting Serious About Suicide Prevention 2Health News:Rae unveils Health-care Strategy 2(Date:7/23/2008)... SEATTLE, July 23 /- D...ed that it expects the Independent Data,Monitoring...terim analysis,of overall survival relating to the...ate AdenoCarcinoma Treatment, also known as D9902B...OVENGE is the Company,s investigational,active cel...
(Date:7/22/2008)... Latest awards under Therapeutics Development...ollaborations to 23; next deadline January 20,200...s part of its mission to,speed delivery of transfo...ase, The Michael J. Fox Foundation for Parkinson,s...g to six industry research teams. The awards,were ...
(Date:7/22/2008)... CEO Geoffrey Allan Will Stress the Importance...On Biologics Approval Pathway, RICHMOND, Va., Jul...,CM: INSM) a developer of follow-on biologics and ...Allan, Ph.D., CEO of Insmed, will present at a,Con...discuss the,significant need for establishing an a...
(Date:7/22/2008)... SOPHIA ANTIPOLIS, France, July 22 /PRNewswir...oday announced it has successfully completed the,e... controlled hypertension,in two clinical pharmacol...viously announced timelines. These trials are desi...xcinod, in comparison to ibuprofen and,naproxen, u...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Harlequin frog rediscovered in remote region of Colombia 2472 1Harlequin frog rediscovered in remote region of Colombia 2472 2SEIU 3A Thousands of Ohio Nurses and Other Healthcare Employees Denied a Voice at Work After Vicious Union Busting Campaign by the California Nurses A 14072 1SEIU 3A Thousands of Ohio Nurses and Other Healthcare Employees Denied a Voice at Work After Vicious Union Busting Campaign by the California Nurses A 14072 2Red light cameras increase crashes researchers find 14068 1Red light cameras increase crashes researchers find 14068 2Red light cameras increase crashes researchers find 14068 3New twist on lifes power source 2468 1New twist on lifes power source 2468 2New twist on lifes power source 2468 3.../PRNewswire-FirstCall/ --,Alpharma Inc. , a leadin...its Pharmaceuticals Division, this week presented ... investigational,abuse-deterrent, extended-release...he American Pain Society in Washington, D.C.,The d...is,extended-release morphine sulfate plus sequeste...
...lank" href=,"http://www.omxgroup.com/">www.omxgrou...Y) , , STOCKHOLM, Sweden, May 3, 2007 – Du...he Sweden-Seattle Diabetes Conference,this past we...,Investigator in Diamyd’s previously reporte...esented potentially scientifically,ground-breaking...
Other Medicine Technology:Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 2Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 3Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 4Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine 5...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: